Bulletin
Investor Alert

Amneal Pharmaceuticals Inc.

NYS: AMRX

GO
/marketstate/country/us

After Hours

/zigman2/quotes/209301288/composite

$

3.96

Change

0.00 0.00%

Volume

Volume 2,276

Sep 25, 2020, 4:02 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/209301288/composite

Previous close

$ 3.82

$ 3.96

Change

+0.14 +3.66%

Day low

Day high

$3.76

$4.00

Open
Open: 3.76

52 week low

52 week high

$2.40

$5.79

Open

Market cap

$1.19B

Average volume

1.12M

P/E ratio

N/A

Rev. per Employee

$277,165

EPS

-1.56

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/amrx

MarketWatch News on AMRX

  1. Demand Spikes for a Drug Studied as Covid-19 Cure

    9:58 a.m. March 24, 2020

    - Barron's Online

  2. Amneal Pharma price target raised to $6 vs. $4 at SunTrust Robinson Humphrey

    9:07 a.m. Dec. 13, 2019

    - Ciara Linnane

  3. Amneal stock jumps on launch of first generic NuvaRing

    10:05 a.m. Dec. 12, 2019

    - Jaimy Lee

  4. AmerisourceBergen shares slide 2.4%; J&J down 0.7%

    1:58 p.m. Nov. 26, 2019

    - Ciara Linnane

  5. Amneal Pharma stock slides 9.3% and Mallinckrodt shares down 1.7%

    1:58 p.m. Nov. 26, 2019

    - Ciara Linnane

  6. McKesson shares slide 3.45, Teva down 8.2%

    1:58 p.m. Nov. 26, 2019

    - Ciara Linnane

  7. Brooklyn Federal prosecutors open criminal probe of opioid makers and distributors: WSJ

    1:56 p.m. Nov. 26, 2019

    - Ciara Linnane

  8. Teva, McKesson, Mallinckrodt, AmerisourceBergen, J&J and Amneal subpoenaed in probe: WSJ

    1:57 p.m. Nov. 26, 2019

    - Ciara Linnane

  9. Amneal Pharmaceuticals downgraded to underweight from neutral at J.P. Morgan

    8:00 a.m. Nov. 12, 2019

    - Tomi Kilgore

  10. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/amrx

Other News on AMRX

  1. 10-Q: AMNEAL PHARMACEUTICALS, INC.

    4:39 p.m. Aug. 6, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  2. Notable earnings before Thursday's open

    1:25 p.m. Aug. 5, 2020

    - Seeking Alpha

  3. Amneal Pharmaceuticals Q2 2020 Earnings Preview

    12:51 p.m. Aug. 5, 2020

    - Seeking Alpha

  4. Amneal (AMRX) to Report Q2 Earnings: What's in the Cards?

    12:08 p.m. Aug. 3, 2020

    - Zacks.com

  5. Can Amneal (AMRX) Keep the Earnings Surprise Streak Alive?

    12:10 p.m. July 22, 2020

    - Zacks.com

  6. Lannett to cut jobs after FDA approves a competing generic drug

    10:39 a.m. July 13, 2020

    - Seeking Alpha

  7. Lannett to cut jobs after FDA OKs competing generic

    10:39 a.m. July 13, 2020

    - Seeking Alpha

  8. Company News for Jul 13, 2020

    9:44 a.m. July 13, 2020

    - Zacks.com

  9. FDA OKs Amneal generic fluphenazine

    8:11 a.m. July 10, 2020

    - Seeking Alpha

  10. Loading more headlines...
/news/pressrelease/company/us/amrx

Press Releases on AMRX

  1. Cyclophosphamide Market Analysis, Status and Business Outlook 2020 to 2025

    12:04 a.m. Sept. 3, 2020

    - Market Insight Reports

  2. Wishbone Medical Appoints Jeff George to Board of Directors

    8:11 a.m. Aug. 12, 2020

    - GlobeNewswire

  3. Amneal Reports Second Quarter 2020 Financial Results

    7:25 a.m. Aug. 6, 2020

    - BusinessWire - BZX

  4. Amneal Launches Generic Fluphenazine Following ANDA Approval by FDA

    8:00 a.m. July 10, 2020

    - BusinessWire - BZX

  5. Amneal to Report Second Quarter 2020 Results on August 6, 2020

    8:00 a.m. July 8, 2020

    - BusinessWire - BZX

  6. Loading more headlines...

Rates »

Link to MarketWatch's Slice.